Mylan offers about $29B for rival generic drugmaker Perrigo

April 8, 2015 9:10 PM

64 0

In a deal that would combine two generic drugmakers that recently left the U.S. for Europe, Mylan says it wants to buy Perrigo for $205 per share, or $28.86 billion.

Shares of both companies climbed to all-time highs on the news. If they combine, Mylan and Perrigo would become one of the world's largest makers of generic and over-the-counter medicines.

Also read: EU sees signs of improvement after Google antitrust shopping case

Read more

To category page